Recombinant SARS-COV-2(2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2(2019-nCoV) Nucleocapsid (Accession # QHD43423.2) fused with an 6XHis tag at the N-terminus.
Synonyms: Nucleocapsid protein; Nucleoprotein; Protein N
Purity: >95% (HPLC); >95% (SDS-PAGE)
Storage: -20C
Biochem Physiol Actions: Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-COV-2 Nucleocapsid at 2mug/mL (100 muL/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL. Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 envelope Protein at 2mug/mL (100 muL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid protein, the EC50 of Recombinant SARS-CoV-2 Nucleocapsid protein is 41.10 ng/mL.